Cohort Dates: September 16, 2021 – January 5, 2022. (The next cohort starts in late January until April 5, 2022.)
The size of the cohort is up to 8 firms. No Cost.
The National Institutes of Health, Food and Drug Administration and the Centers for Disease Control SBIR/STTR programs invest over 1 billion dollars into health and life science companies that are creating innovative technologies that align with NIH/FDA/CDC’s mission to improve health and save lives. A key objective is to translate promising technologies to the private sector and enable life-saving innovations to reach consumer markets.
As an approved Accelerator Cohort participant, we will help you and your team prepare and submit a high-quality grant application for funding consideration. There are many steps in the process. We provide the expertise and the navigation for you through 1:1 individualized and customized assistance. Our assistance is free and delivered through weekly online meetings on Thursday at a mutually agreed time.
The Cohort content includes, but not limited to:
- NIH SBIR/STTR Deep Dive – September 16th, 9 AM – 12 PM (Mandatory Session)
- Funding Opportunity Announcements
- Electronic Registrations
- Program Director Communications
- Institute/Study Section Selection
- Research Area – Topic Selection (Waived vs Non-Waived)
- Clinical Trial vs Non-Clinical Trial
- Planning the R&D Project
- Proposal Requirements
- Project Narrative
- Project Summary
- Specific Aims
- Research Strategy
- Biographical Sketches
- Indirect Cost Rate Determination